Loading...

Roche Holding AG

RHHBF•PNK
Healthcare
Drug Manufacturers - General
$419.50
$0.00(0.00%)
U.S. Market opens in 7h 53m

Roche Holding AG (RHHBF) Stock Overview

Explore Roche Holding AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap333.9B
P/E Ratio28.57
EPS (TTM)$20.43
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$407.29
3 Months$413.12
1 Year Target$337.50

RHHBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Roche Holding AG (RHHBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $337.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.57 and a market capitalization of 333.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
0.72%
1-Month Change
9.57%
3-Month Change
-10.27%
6-Month Change
18.84%
Year-to-Date (YTD) Change
-5.86%
1-Year Change
16.85%
3-Year Change
26.07%
5-Year Change
19.85%
All-Time (Max) Change
235.60%

Contact Information

https://www.roche.com
41 61 688 11 11
Konzern Hauptsitz, Basel, NaN, 4070

Company Facts

103,249 Employees
IPO DateAug 3, 2012
CountryCH
Actively Trading

Frequently Asked Questions